A randomized, double-blind, placebo-controlled, cross-over trial to evaluate the effect of EstroSense® on 2-hydroxyestrone:16α-hydroxyestrone ratio in premenopausal women
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Complementary and Integrative Medicine"
DOI: 10.1515/jcim-2022-0301
Abstract: Abstract Objectives Some estrogen metabolites are associated with increased breast cancer risk, while others are protective. Research efforts have focused on modifiable factors, including bioactive compounds found in food or supplements, promoting estrogen profiles with… read more here.
Keywords: hydroxyestrone hydroxyestrone; estrosense; ohe1; placebo ... See more keywords